4 Analysts Assess Ingevity: What You Need To Know

Ingevity (NYSE:NGVT) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

	Bullish	Somewhat Bullish	Indifferent	Somewhat Bearish	Bearish
Total Ratings	0	1	3	0	0
Last 30D	0	0	1	0	0
1M Ago	0	0	0	0	0
2M Ago	0	1	1	0	0
3M Ago	0	0	1	0	0

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.5, a high estimate of $70.00, and a low estimate of $55.00. This current average has increased by 8.23% from the previous average price target of $57.75.

Decoding Analyst Ratings: A Detailed Look

A clear picture of Ingevity's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst	Analyst Firm	Action Taken	Rating	Current Price Target	Prior Price Target
Michael Sison	Wells Fargo	Raises	Equal-Weight	$65.00	$60.00
Michael Sison	Wells Fargo	Raises	Equal-Weight	$60.00	$55.00
John McNulty	BMO Capital	Raises	Outperform	$70.00	$64.00
Michael Sison	Wells Fargo	Raises	Equal-Weight	$55.00	$52.00

Key Insights:

• Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Ingevity. This insight gives a snapshot of analysts' perspectives on the current state of the company.
• Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ingevity compared to the broader market.
• Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Ingevity's stock. This comparison reveals trends in analysts' expectations over time.

To gain a panoramic view of Ingevity's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.

Stay up to date on Ingevity analyst ratings.

About Ingevity

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Financial Milestones: Ingevity's Journey

Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.

Decline in Revenue: Over the 3M period, Ingevity faced challenges, resulting in a decline of approximately -0.21% in revenue growth as of 30 September, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.

Net Margin: Ingevity's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 13.06%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): Ingevity's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 33.62%, the company showcases efficient use of equity capital and strong financial health.

Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.34%, the company showcases effective utilization of assets.

Debt Management: Ingevity's debt-to-equity ratio surpasses industry norms, standing at 9.35. This suggests the company carries a substantial amount of debt, posing potential financial challenges.

How Are Analyst Ratings Determined?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.